Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Head & Neck|March 2, 2017
Neoadjuvant chemotherapy in geriatric head and neck cancersVijay M Patil, Vanita Noronha, Amit Joshi, et al.
International Journal of Surgical Oncology|March 9, 2016
Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation)Vijay M Patil, Amit Joshi, Vanita Noronha, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2025
Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptomsFraser Paterson, Jing Yuan On, Dania Ahmed, et al.
Oral Oncology|January 13, 2015
A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neckVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
South Asian Journal of Cancer|February 7, 2018
EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burdenAmit Joshi, Vijay M Patil, Vanita Noronha, et al.
Cancer Medicine|March 28, 2022
Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatinNandini S Menon, Vanita Noronha, Vijay Maruti Patil, et al.
Respiratory Medicine|May 29, 2025
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthmaMarcello Cottini, Remo Poto, Atanu Bhattacharjee, et al.
South Asian Journal of Cancer|November 16, 2018
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.
Progress in Cardiovascular Diseases|October 1, 2023
Self-reported walking pace and 10-year cause-specific mortality: A UK biobank investigationJonathan Goldney, Paddy C Dempsey, Joseph Henson, et al.
Oral Oncology|December 12, 2017
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancerAmit Joshi, Vijay Patil, Vanita Noronha, et al.
Pageof 16